Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Notes underwriting agrmnt
Inv. presentation
Quarterly results
Acq. announced
Vistagen Therapeutics, Inc. (VTGN) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/12/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
10/06/2023 4 COMMODORE CAPITAL LP (10% Owner) has filed a Form 4 on Vistagen Therapeutics, Inc.
Txns: Granted 2,788,620 options to buy @ $0.001, valued at $2.8k
Granted 1,394,310 options to buy @ $5.38, valued at $7.5M
Granted 1,690,014 options to buy @ $8.877, valued at $15M
10/06/2023 SC 13G/A COMMODORE CAPITAL LP reports a 9.9% stake in Vistagen Therapeutics, Inc.
10/05/2023 SC 13G Point72 Asset Management, L.P. reports a 5.6% stake in Vistagen Therapeutics, Inc.
10/04/2023 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits ...
Docs: " ",
" ",
" ",
" ",
" ",
" ",
" "
10/03/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
10/02/2023 8-K Quarterly results
09/29/2023 8-K Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits  Interactive Data
08/23/2023 4 Anderson Cynthia Lynn (CFO) has filed a Form 4 on Vistagen Therapeutics, Inc.
Txns: Granted 8,333 options to buy @ $5.34, valued at $44.5k
08/23/2023 3 Anderson Cynthia Lynn (CFO) has filed a Form 3 on Vistagen Therapeutics, Inc.
08/22/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: " "
08/10/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/10/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: " "
08/09/2023 SC 13G COMMODORE CAPITAL LP reports a 19.7% stake in Vistagen Therapeutics, Inc.
08/09/2023 4 COMMODORE CAPITAL LP (10% Owner) has filed a Form 4 on Vistagen Therapeutics, Inc.
Txns: Bought 775,756 shares @ $23.153, valued at $18M
08/09/2023 3 COMMODORE CAPITAL LP (10% Owner) has filed a Form 3 on Vistagen Therapeutics, Inc.
08/08/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
08/07/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: " "
07/28/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
07/28/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
07/18/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: " "
07/13/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: " "
07/07/2023 SC 13G/A BlackRock Inc. reports a 0% stake in VistaGen Therapeutics, Inc.
07/07/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
07/05/2023 4 Singh Shawn (CEO) has filed a Form 4 on Vistagen Therapeutics, Inc.
Txns: Granted 167 shares @ $1.5895, valued at $265.4
07/05/2023 4 Adler Reid G. (CHIEF LEGAL OFFICER) has filed a Form 4 on Vistagen Therapeutics, Inc.
Txns: Granted 167 shares @ $1.5895, valued at $265.4
07/05/2023 4 DOTSON JERROLD DUANE (VP, CFO) has filed a Form 4 on Vistagen Therapeutics, Inc.
Txns: Granted 167 shares @ $1.5895, valued at $265.4
06/30/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
06/28/2023 10-K Annual Report for the period ended March 31, 2023
06/28/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: " "
06/07/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: " "
06/01/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: " "
04/19/2023 8-K Quarterly results
04/06/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: " "
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy